FDA Clearance Tracker · P960009-S408
Activa® Deep Brain Stimulation Therapy System, Percept PC BrainSense
Last checked: Nov 20, 2026Latest source record: Feb 18, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Feb 18, 2022
Approved
Time to decision
164 days
Received Sep 7, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P960009-S408
- Device name
- Activa® Deep Brain Stimulation Therapy System, Percept PC BrainSense
- Applicant
- Medtronic, Inc.
- Applicant location
- Minneapolis, MN
- Received
- Sep 7, 2021
- Decided
- Feb 18, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P960009
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for the use of electronic labeling as a primary medium for distributing Neuromodulation and Pelvic Health product labeling to patients.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.